Parnell Pharmaceuticals Holdings Ltd. reported un-audited earnings results for the six months ended June 30, 2015. For the six months, the company reported revenue of AUD 4,927,965 compared to AUD 4,698,606, loss before income tax of AUD 2,983,338 compared to AUD 9,936,426 and loss of AUD 2,985,444 or AUD 0.22 per basic and diluted share compared to AUD 12,916,838 or AUD 1.54 per basic and diluted share for the last year.

The company expected sales in Companion Animal segment to increase significantly in the second half of 2015 and to deliver 2015 full year results in line with guidance.